Magenta Therapeutics Inc MGTA:NASDAQ

Last Price$1.31NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+0.11(9.17%)
Bid (Size)$1.35 (15)
Ask (Size)$1.61 (20)
Day Low / High$1.19 - 1.31
Volume123.3 K
  • Latest Stories
  • Commentary and Analysis
Goldman Sachs Adjusts Price Target for Magenta Therapeutics to $2 From $3, Keeps Buy Rating
11:31AM ET 5/24/2022 MT Newswires

Magenta Therapeutics (MGTA) has an average buy rating among analysts, with a price target range of $2 to $20. (MT Newswires covers equity, commodity and...

Wedbush Adjusts Magenta Therapeutics Price Target to $6 From $7, Maintains Outperform Rating
12:51PM ET 5/16/2022 MT Newswires

Magenta Therapeutics (MGTA) has an average rating of Buy and price targets ranging from $6 to $8, according to analysts polled by Capital IQ. (MT Newswires...

Magenta Therapeutics Shares Drop After Slew of Target Cuts
1:32PM ET 4/18/2022 MT Newswires

Magenta Therapeutics (MGTA) shares were down almost 10% on Monday afternoon after a series of price-target cuts. Mizuho Securities cut the price target to...

Mizuho Securities Adjusts Magenta Therapeutics' Price Target to $8 From $17, Reiterates Buy Rating
7:34AM ET 4/18/2022 MT Newswires

Magenta Therapeutics (MGTA) has an average rating of buy and price targets ranging from $6 to $8, according to analysts polled by Capital IQ. (MT Newswires...

BTIG Adjusts Magenta Therapeutics' Price Target to $6 From $10, Reiterates Buy Rating
7:26AM ET 4/18/2022 MT Newswires

Magenta Therapeutics (MGTA) has an average rating of buy and price targets ranging from $6 to $8, according to analysts polled by Capital IQ. (MT Newswires...

Sector Update: Health Care Stocks Fading Late, Stop Just Shy of Higher Close
3:56PM ET 4/14/2022 MT Newswires

Health care stocks were narrowly lower this afternoon, with the NYSE Health Care Index slipping 0.1% and the SPDR Health Care Select Sector ETF (XLV) down...

Sector Update: Health Care Stocks Edging Lower on Thursday
1:08PM ET 4/14/2022 MT Newswires

Health care stocks were narrowly lower this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) down 0.2%. The...

Wedbush Adjusts Magenta Therapeutics Price Target to $7 From $9, Maintains Outperform Rating
12:16PM ET 4/14/2022 MT Newswires

Magenta Therapeutics (MGTA) has an average rating of Buy and price targets ranging from $6 to $17, according to analysts polled by Capital IQ. (MT...

Magenta Therapeutics to Focus Capital Spending on Leukemia Drug Trial, Cut Workforce by 14%
10:08AM ET 4/14/2022 MT Newswires

Magenta Therapeutics (MGTA) said Thursday it is planning to focus capital spending on its ongoing development of MGTA-117 as a potential treatment for...

Wedbush Adjusts Magenta Therapeutics Price Target to $9 From $14, Maintains Outperform Rating
1:56PM ET 3/08/2022 MT Newswires

Magenta Therapeutics (MGTA) has an average rating of Buy and price targets ranging from $6 to $20, according to analysts polled by Capital IQ. (MT...